Herpes simplex virus thymidine kinase and ganciclovir suicide gene therapy for human pancreatic cancer

World Journal of Gastroenterology

Volumn 10, Issue 3, 2004, Pages 400-403

  Wang, Jing ^a   Lu, Xiao Xuan ^a   Chen, Dao Zhen ^a   Li, Shu Feng ^a   Zhang, Li Shan ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; GANCICLOVIR; NUCLEOTIDE DERIVATIVE; RETROVIRUS VECTOR; THYMIDINE KINASE;

ANIMAL CELL; ARTICLE; BYSTANDER EFFECT; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SENSITIVITY; GENE TRANSFER; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PANCREAS CANCER; PROGENY; SUICIDE GENE THERAPY; TARGET CELL; VIRAL GENE THERAPY; VIRION; VIRUS RECOMBINANT; VIRUS REPLICATION;

EID: 1142263304     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i3.400     Document Type: Article

References (24)

1. Lorenz M, Heinrich S. Regional chemotherapy. Hematol Oncol Clin North Am 2002; 16: 199-215
2. Gustin A, Pederson L, Miller R, Chan C, Vickers SM. Application of molecular biology studies to gene therapy treatment strategies. World J Surg 2002; 26: 854-860
3. Shankar A, Russell RC. Recent advances in the surgical treatment of pancreatic cancer. World J Gastroenterol 2001; 7: 622-626
4. McAuliffe PF, Jarnagin WR, Johnson P, Delman KA, Federoff H, Fong Y. Effective treatment of pancreatic tumors with two multimutated herpes simplex oncolytic viruses. J Gastrointest Surg 2000; 4: 580-588
5. Makinen K, Loimas S, Wahlfors J, Alhava E, Janne J. Evaluation of herpes simplex thymidine kinase mediated gene therapy in experiment pancreatic cancer. J Gene Med 2000; 2: 361-367
6. Xu CT, Huang LT, Pan BR. Current gene therapy for stomach carcinoma. World J Gastroenterol 2001; 7: 752-759
7. Fukui T, Hayashi Y, Kagami H, Yamamoto N, Fukuhara H, Tohnai I, Ueda M, Mizuno M, Yoshida J. Suicide gene therapy for human oral squamous cell carcinoma cell lines with adeno-associated virus vector. Oral Oncol 2001; 37: 211-215
8. Jiang BJ, Sun RX, Lin H, Gao YF. Study on the risk factors of lymphatic metastasis and the indications of less invasive operations in early gastric cancer. World J Gastroenterol 2000; 6: 553-556
9. Robe PA, Princen F, Martin D, Malgrange B, Stevenaert A, Moonen G, Gielen J, Merville M, Bours V. Pharmacological modulation of the bystander effect in the herpes simplex virus thymidine kinase/ganciclovir gene therapy system: Effects of dibutyryl adenosine 3′,5′-cyclic monophosphate, alpha-glycyrrhetinic acid, and cytosine arabinoside. Biochem Pharmacol 2000; 60: 241-249
10. Craperi D, Vicat JM, Nissou MF, Mathieu J, Baudier J, Benabid AL, Verna JM. Increased bax expression is associated with cell death induced by ganciclovir in a herpes thymidine kinase gene-expressing glioma cell line. Hum Gene Ther 1999; 10: 679-688
11. Halloran CM, Ghaneh P, Neoptolemos JP, Costello E. Gene therapy for pancreatic cancer - Current and prospective strategies. Surg Oncol 2000; 9: 181-191
12. Gilliam AD, Watson SA. Emerging biological therapies for pancreatic carcinoma. Eur J Surg Oncol 2002; 28: 370-378
13. Nagasawa H, Cremesti A, Kolesnick R, Fuks Z, Little JB. Involvement of membrane signaling in the bystander effect in irradiated cells. Cancer Res 2002; 62: 2531-2534
14. Shalev M, Miles BJ, Thompson TC, Ayala G, Butler EB, Aguilar-Cordova E, Kadmon D. Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpes virus thymidine kinase gene. World J Urol 2000; 18: 125-129
15. Carrio M, Visa J, Cascante A, Estivill X, Fillat C. Intratumoral activation of cyclophosphamide by retroviral transfer of the cytochrome P450 2B1 in a pancreatic tumor model. Combination with the HSVtk/GCV system. J Gene Med 2002; 4: 141-149
16. Kleeff J, Fukahi K, Lopez ME, Friess H, Buchler MW, Sosnowski BA, Korc M. Targeting of suicide gene delivery in pancreatic cancer cells via FGF receptors. Cancer Gene Ther 2002; 9: 522-532
17. Gazdar AF, Minna JD, Targeted therapies for killing tumor cells. Proc Natl Acad Sci U S A 2001; 98: 10028-10030
18. Ghaneh P, Greenhalf W, Humphreys M, Wilson D, Zumstein L, Lemoine NR, Neoptolemos JP. Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo. Gene Ther 2001; 8: 199-208
19. Zheng M, Liu LX, Zhu AL, Qi SY, Jiang HC, Xiao ZY. K-ras gene mutation in the diagnosis of ultrasound guided fine-needle biopsy of pancreatic masses. World J Gastroenterol 2003; 9: 188-191
20. Kawakami K, Kawakami M, Husain SR, Puri RK. Targeting interleukin-4 receptors for effective pancreatic cancer therapy. Cancer Res 2002; 62: 3575-3580
21. Dong YB, Yang HL, Elliott MJ, McMasters KM. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors. Cancer Res 2002; 62: 1776-1783
22. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-553
23. Paddison PJ, Caudy AA, Hannon GJ. Stable suppression of gene expression by RNAi in mammalian cells. Proc Natl Acad Sci U S A 2002; 99: 1443-1448
24. Borkhardt A. Blocking oncogenes in malignant cells by RNA interference - New hope for a highly specific cancer treatment? Cancer Cell 2002; 2: 167-168